Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial membrane proteins and lipids constitute the essential structural and functional components of the bacterial cell envelope, which separates the cytoplasm from the external environment (Silhavy et al., 2010). These components include the cytoplasmic (inner) membrane, the cell wall (peptidoglycan), and, in Gram-negative bacteria, an additional outer membrane rich in lipopolysaccharides (LPS) (Nikaido, 2003). Membrane proteins such as penicillin-binding proteins (PBPs), porins, and efflux pumps facilitate cell wall synthesis, nutrient transport, and drug resistance, while lipids like phosphatidylglycerol and cardiolipin maintain membrane fluidity and integrity (Sauvage et al., 2008; Sohlenkamp & Geiger, 2016). Because these structures are often unique to bacteria or significantly different from eukaryotic counterparts, they serve as primary targets for numerous antibiotic classes (Lewis, 2013). For example, polymyxins disrupt the outer membrane of Gram-negative bacteria by binding to LPS, while daptomycin inserts into the cytoplasmic membrane of Gram-positive bacteria, causing depolarization and cell death (Landman et al., 2008; Humphries et al., 2013). Targeting these components is a cornerstone of treating bacterial infections, though challenges such as membrane-mediated resistance and host toxicity remain significant concerns (Trimpa et al., 2016).
Drugs targeting these components act by disrupting membrane integrity, inhibiting cell wall biosynthesis (e.g., via penicillin-binding proteins), forming transmembrane pores that lead to ion leakage, or inhibiting membrane-associated enzymes and lipid carriers.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial membrane proteins and lipids.